CG Oncology
CG Oncology is seeking a Pharmacovigilance Operations Manager to lead and manage pharmacovigilance activities during critical transitions from clinical development to commercialization. The role involves building a compliant and scalable PV organization, overseeing vendor relationships, and supporting post-marketing safety efforts in a fast-paced, growth-oriented biotech environment.
CG Oncology is a late-stage biopharmaceutical company focused on developing bladder‑sparing immunotherapies for bladder cancer. The company specializes in oncolytic immunotherapy and is advancing cretostimogene grenadenorepvec as a lead therapeutic candidate. CG Oncology’s programs aim to provide non-surgical, targeted treatment options that preserve the bladder and improve outcomes for patients with bladder cancer. They emphasize clinical development and commercialization readiness to bring these innovative therapies to market.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CG Oncology.
71% above the average for this role
Associate Director, Pharmacovigilance (PV) Commercial Liaison, Global Clinical Safety and Pharmacovigilance
Madrigal Pharmaceuticals
Senior Director - Head of PV
Cascadia Search Group
Senior Director, Product Quality Lead (Post-Marketing and Pharmacovigilance
Madrigal Pharmaceuticals
Pharmacovigilance (PV) Specialist
Rhythm Pharmaceuticals
Principal Pharmacovigilance Specialist - External partner management
Novo Nordisk A/S
Director, Pharmacovigilance Quality Assurance
Dyne Therapeutics